PRE 14A

OXIGENE, INC.

Company: Oncotelic Therapeutics, Inc.
Filed: February 7, 2011
Period of Report: February 7, 2011
Accession Number: 0000950123-11-009842

View Document ↗ View on SEC.gov ↗